Treg Depletion Attenuates Irradiation-induced Pulmonary Fibrosis by Reducing Fibrocyte Accumulation, Inducing Th17 Response, and Shifting IFN-γ, IL-12/IL-4, IL-5 Balance
Overview
Authors
Affiliations
Irradiation-induced pulmonary fibrosis results from thoracic radiotherapy and severely limits radiotherapy approaches. CD4(+) CD25(+) FoxP3(+) regulatory T cells (Tregs) are involved in experimentally induced murine lung fibrosis. However, the precise contribution of Tregs to irradiation-induced pulmonary fibrosis still remains unclear. We have previously established the mouse model of irradiation-induced pulmonary fibrosis and observed an increased frequency of Tregs during the process. This study aimed to investigate the effects of Treg depletion on irradiation-induced pulmonary fibrosis and on fibrocyte, Th17 cell response and production of multiple cytokines in mice. Treg-depleted mice were generated by intraperitoneal injection with anti-CD25 mAb 2h after 20 Gy (60)CO γ-ray thoracic irradiation and every 7 days thereafter. Pulmonary fibrosis was semi-quantitatively assessed using Masson's trichrome staining. The proportions of Tregs, fibrocyte and Th17 cells were detected by flow cytometry. Th1/Th2 cytokines were assessed by Luminex assays. We found that Treg depletion decelerated the process of irradiation-induced pulmonary fibrosis and hindered fibrocyte recruitment to the lung. In response to Treg depletion, the number of CD4(+) T lymphocytes and Th17 cells increased. Moreover, Th1/Th2 cytokine balance was disturbed into Th1 dominance upon Treg depletion. Our study demonstrates that Tregs are involved in irradiation-induced pulmonary fibrosis by promoting fibrocyte accumulation, attenuating Th17 response and regulating Th1/Th2 cytokine balance in the lung tissues, which suggests that Tregs may be therapeutically manipulated to decelerate the progression of irradiation-induced pulmonary fibrosis.
Maciejewska A, Czernia P, Piotrowska-Mieczkowska M, Wajda B, Slominski B, Romantowski J Front Immunol. 2025; 15():1436491.
PMID: 39845961 PMC: 11750670. DOI: 10.3389/fimmu.2024.1436491.
Ge X, Liu Q, Fan H, Yu H, Li J, Li Y Transl Lung Cancer Res. 2024; 13(11):3010-3025.
PMID: 39670000 PMC: 11632424. DOI: 10.21037/tlcr-24-649.
Li H, Wang J, Li Z, Wu Z, Zhang Y, Kong L Heliyon. 2024; 10(20):e39150.
PMID: 39640640 PMC: 11620036. DOI: 10.1016/j.heliyon.2024.e39150.
Immune mechanisms in fibrotic interstitial lung disease.
Kamiya M, Carter H, Espindola M, Doyle T, Lee J, Merriam L Cell. 2024; 187(14):3506-3530.
PMID: 38996486 PMC: 11246539. DOI: 10.1016/j.cell.2024.05.015.
Treg-tissue cell interactions in repair and regeneration.
Loffredo L, Savage T, Ringham O, Arpaia N J Exp Med. 2024; 221(6).
PMID: 38668758 PMC: 11046849. DOI: 10.1084/jem.20231244.